medigraphic.com

2004, Number 1

<< Back Next >>

Arch Cardiol Mex 2004; 74 (1)

Changes in cardiac metabolism and their possible use in therapeutics (Part II)

Carbó R, Guarner V

Language: Spanish
References: 81
Page: 68-79
PDF size: 139.85 Kb.


ABSTRACT

Based on the cardiac metabolic changes during hypoxia, in this second part of our review we propose, the polarizing solution as an alternative for the maintenance of the cardiac cells during an infarction, in conjunction with other alternative therapies.


REFERENCES

  1. Stanley WC, Lopaschuck GD, Hall JL, McCormack JG: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Cardiovasc Res 1997; 33: 243-257.

  2. Carbó R, Guarner V: Cambios en el metabolismo cardíaco y su posible aprovechamiento en la terapéutica (parte I). Arch Cardiol Mex 2003; 73(3): 218-229.

  3. Lopaschuck GD, Stanley WC: Manipulation of energy metabolism in the heart. Science Medicine 1997; 6: 42-51.

  4. Schofield RS, Hill JA: Role of metabolically active drugs in the management of ischemic heart disease. Am J Cardiovasc Drugs 2001; 1(1): 23-35.

  5. Russel RR, Mommessin JI, Taegtmeyer H: Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 1995; 268: H441-H447.

  6. Rao V, Merante F, Weisel RD, Shirai T, Ikonomidis JS, Cohen G, et al: Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from stimulated ischemia. J Thorac Cardiovasc Surg 1998; 116(3): 485-494.

  7. Sodi Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, De Micheli A: Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962; 9(2): 166-181.

  8. Morgan HE, Henderson MJ, Regen DM, Park CR: Regulation of glucose uptake in muscle. J Biol Chem 1961; 236(2): 253-261.

  9. Weissler AM, Kruger FA, Baba N, Scarpelli DG, Leighton RF, Gallimore JK: Role of anaerobic metabolism in the preservation of functional capacity and structure of anoxic myocardium. J Clin Invest 1968; (2): 403-416.

  10. Opie LH, Owen P: Effect of glucose-insulin-potassium infusions as arteriovenous differences of glucose and of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction. Am J Cardiol 1976; 38: 310-321.

  11. Mittra B: Resolution of electrocardiographic signs of myocardial infarction after potassium, glucose and insulin therapy. Postgrad Med J 1967; 43(505): 701-705.

  12. Watanabe KN, Yoshihara K, Tokuhiro K, Horikoshi J, Tanaka T, Shionop N, et al: Clinical assessment of myocardial protection with blood-GIK solution. Rinsho Kyobu Geka 1989; 9(2): 169-172.

  13. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH: Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80(3A): 3A-10A.

  14. Lopaschuk G: Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 2000; 139(2 prt3): S115-S119.

  15. Cotterill JA, Hughes JP, Jones R, Paulley JW, Robertson PD: G.I.K. for myocardial infarction. Lancet 1970; 1: 1176-1177.

  16. Díaz R, Paolasso EA, Piegas L, Tajer CD, Moreno MG, Corvalán R, et al: Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. Circulation 1998; 98(21): 2227-2234.

  17. Arós F, Loma-Osorio A: La terapia con glucosa-insulina-potasio reduce complicaciones en la fase aguda del infarto de miocardio. Argumentos en contra. Rev Esp Cardiol 1998; 51: 727-731.

  18. Calva E, Mujica A, Núñez R: Algunos procesos bioquímicos en los sarcosomas del tejido infartado y el efecto de la solución polarizante. Arch Inst Cardiol Mex 1964; 34: 704-711.

  19. Calva E, Mujica A, Núñez R, Aoki K, Bisteni A, Sodi Pallares D: Mitochondrial biochemical changes and glucose-KCl-insulin solution in cardiac infarct. Am J Physiol 1966; 211: 71-76.

  20. Calva E, Mujica A, Bisteni A, Sodi Pallares D: Oxidative phosphorylation in cardiac infarct. Effect of glucose-KCl-insulin solution. Am J Physiol 1965; 209: 371-375.

  21. 21.Maroko PR, Libby P, Sobel BE, Bloor CM, Shell WE, Braunwald E: Glucose-insulin-potassium induced reductions in experimental myocardial infarction size following acute coronary occlusion. Circulation 1971; 43-44: suppl (II)197-210.

  22. Rogers WJ, Russell RO, McDaniel HG, Rackley CE: Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am J Cardiol 1977; 40: 421-427.

  23. Coleman GM, Gradinac S, Taegtmeyer H, Sweeney M, Frazier H: Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery. Circulation 1989; 80(Suppl I): I-91- I-96.

  24. Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO, Rackley CE: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Am J Cardiol 1979; 43: 801-809.

  25. Stanley AW, Moraski RE, Russell RO Jr, Rogers WJ, Mantle JA, Kriesberg RA, et al: Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Am J Cardiol 1975; 36: 929-936.

  26. Medrano GA: Alteraciones electrocardiográficas e iónicas en el infarto agudo del miocardio con y sin tratamiento polarizante. Arch Inst Cardiol Mex 1964; 34: 696-704.

  27. Apstein CS, Gravino FN, Haudenschild CC: Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res 1983; 52(5): 515-526.

  28. De Micheli A, Medrano GA, Sodi Pallares D: Efectos de algunas soluciones electrolíticas sobre la evolución electrocardiográfica del infarto experimental agudo del miocardio. Arch Inst Cardiol Mex 1963; 33: 567-580.

  29. Sodi Pallares D, Bisteni A, Medrano GA, De Micheli A: Polarizing treatment of acute myocardial infarction. Possibility of its use in other cardiovascular conditions. Dis Chest 1963; 43: 424-432.

  30. Sybers HD, Maroko PR, Ashraf M, Libby P, Braunwald E: The effect of glucose-insulin-potassium on cardiac ultrastructure following acute experimental coronary occlusion. Am J Pathol 1973; 70: 401-420.

  31. Hess ML, Okabe E, Poland J, Warner M, Steward JR, Greeenfield LJ: Glucose insulin and potassium protection during the course of hypothermic global ischemia and reperfusion: proposed mechanism by scavenging of free radicals. J Cardiovasc Pharmacol 1983; 5: 35-43.

  32. Braunwald E: The Myocardium: Failure and Infarction. New York HP Publishing Co., Inc. 1974.

  33. Maroko PR, Libby P, Sobel BE, Bloor M, Sybers HD, Shell WE, et al: Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972; 65: 1160-1175.

  34. Carbó R: Efectos de la solución polarizante en la fisiología electromecánica, en las arterias y en la captación de glucosa en corazón normal e hipóxico de rata. Tesis de Doctorado, 2001. CINVESTAV, México.

  35. Sodi Pallares D: Estudio experimental de la contracción miocárdica en el infarto agudo, con y sin solución polarizante. Arch Inst Cardiol Mex 1964; 34: 696-704.

  36. Nava P, Collados MT, Massó F, Guarner V: Endothelin mediation of insulin and glucose induced changes in vascular contractility. Hypertension 1997; 30: 825-829.

  37. Nava P, Carbó R, Guarner V: Coronary and femoral arterial contraction with high glucose, insulin and glucose-insulin-potassium solution: effects of hypoxia. Heart Vessels 2002; 16(2): 57-63.

  38. Ponce de León J: El tratamiento polarizante en el infarto del miocardio y en la insuficiencia cardíaca. Arch Inst Cardiol Mex 1964; 34: 711-718.

  39. De Micheli A: Trayectoria de la eletrovectocardiografía mexicana. Arch Inst Cardiol Mex 1993; 63: 259-266.

  40. Mantle JA, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Russell RO, Rackley CE: Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: Results from a randomized clinical trial. Am Heart J 1981; 102: 313-323.

  41. O´Rourke B, Ramza BM, Marban E: Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science 1994; 265: 962-966.

  42. De Micheli A, Medrano GA, Villareal A, Sodi Pallares D: Efecto protector de la solución glucosa-insulina-potasio en el daño miocárdico producido por emetina. Arch Inst Cardiol Mex 1975; 45: 469-486.

  43. De Micheli A, Medrano GA: ¿Qué debemos entender por isquemia, lesión y necrosis? Arch Inst Cardiol Mex 1994; 64: 205-221.

  44. Katz J, McGarry JD: The glucose paradox. Is glucose a substrate for liver metabolism? J Clin Invest 1984; 74: 1901-1909.

  45. Katz J, Kuwajima M, Foster DW, McGarry JD: The glucose paradox: new perspectives on hepatic carbohydrate metabolism. TIBS 1986; 11: 136-140.

  46. Joost H-S, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, et al: Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Endocrinol Metab 2002; 282: E974-E976.

  47. Pessin JE, Bell GI: Mammalian facilitative glucose transporters family: structure and molecular regulation. Ann Rev Physiol 1992; 54: 911-930.

  48. Gould GW, Holman GD: The glucose transporter family; structure, function and tissue-specific expression. Biochem J 1993; 295: 329-341.

  49. Ganong WF: Fisiología Médica. Editorial El Manual Moderno, 1994.

  50. Mantych GJ, James DE, Devaskar SU: Jejunal/kidney glucose transporter isoform (Glut 5) is expressed in the human blood-brain barrier. Endocrinology 1993; 132(1): 35-40.

  51. Lisinski I, Schürmann A, Joost H-S, Cushman SW, Al-Hasani H: Targeting of Glut 6 (formely Glut 9) and Glut 8 in rat adipose cells. Biochem J 2001; 358: 517-522.

  52. Carayannopoulos MO, Chi MMY, Cui Y, Pingsterhaus JM, McKnight RA, Mueckler M, et al: GLUT 8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocist. Proc Natl Acad Sci 2000; 97(13): 7313-7318.

  53. Rogers S, Macheda ML, Docherty SE, Carty MD, Henderson MA, Soeller WC, et al: Identification of a novel glucose transporter-like protein GLUT 12. AJP Endocrinol Metab 2002; 282(3): E733-E738.

  54. Laybutt DR, Thompson AL, Cooney GJ, Kraegen EW: Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose and lipid in rat cardiac muscle in vivo. Am J Physiol 1997; 273: 3Pt2, H13309-H13316.

  55. Zorzano A, Sevilla L, Camps M, Becker C, Meyer J, Kammermeier H, et al: Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol 1997; 80(3A): 65A-76A.

  56. Brosius FC 3rd, Liu Y, Nguyen N, Sun D, Bartlett J, Schwaiger M: Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non ischemic heart regions. J Mol Cell Cardiol 1997; 29(6): 1675-1685.

  57. Slot JW, Geuze HJ, Gigengack S, James DE, Leinhard GE: Translocation of the glucose transporters GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci 1991; 88: 7815-19.

  58. James DE, Brown R, Navarro J, Pilch PF: Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 1988; 333: 183-185.

  59. Slot JW, Geuze HJ, Gigengack S, Leinhard GE, James DE: Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 1991; 113: 123-135.

  60. Sun D, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC 3rd: Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 1994; 89(2): 793-798.

  61. Young LH, Renfu Y, Russell R, Caplan M, Ren J, Shulman GI, Sinusas AJ: Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 1997; 95(2): 415-422.

  62. Ramasamy R, Hwang YC, Whang J, Bergmann SR: Protection of ischemic heart by high glucose is mediated, in part, by GLUT-4. Am J Physiol 2110; 281(1): H290-H297.

  63. Calderhead DM, Kitawaga K, Tanner LI, Holman GD, Lienhard GE: Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes. J Biol Chem 1990; 265: 13800-13808.

  64. Opie LH: Substrate utilization and glycolysis in the heart. Cardiology 1971/72; 56: 2-21.

  65. Kao, RL, Christman EW, Luh SL, Krauhs JM, Tyers GFO, Williams EH: The effects of insulin and anoxia in the metabolism of isolated mature rat cardiac myocytes. Arch Biochem Biophys 1980; 203: 587-590.

  66. Hougen TJ, Hopkins BE, Smith TW: Insulin effects on monovalent cation transport and Na-K ATPase activity. Am J Physiol 1978; 234(3): C59-C63.

  67. Resnick LM: Hypertension and abnormal glucose homeostasis. Am J Med 1989; 87(6A): 17s-22s.

  68. Epstein M, Sowers JR: Diabetes Mellitus and Hypertension. Hypertension 1992; 19: 403-418.

  69. Levy J, Zemel MB, Sowers JR: Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. Am J Med 1989; 87(Suppl 6A): 7S-16S.

  70. Stralfors P: Insulin stimulation of glucose uptake can be mediated by diacylglycerol in adipocytes. Nature 1988; 335: 554-556-560.

  71. Rosen OM: After insulin binds. Science 1987; 237: 1452-1458.

  72. Graves CB, Gale RD, Laurino JP, McDonald JM: The insulin receptor and calmodulin. J Biol Chem 1986; 261: 10429-10438.

  73. White M, Kahn RJ: The insulin signalling system. J Biol Chem 1994; 269(1): 1-4.

  74. Tsuruzoe K, Emkey R, Kriauciunas KM, Ueki K, Kahn R: Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1 and IRS-2- mediated signaling. Mol Cell Biol 2001; 21(1): 26-38.

  75. Combettes SM, Issad T: Molecular basis of insulin action. Diab Metab 1998; 24(6); 477-489.

  76. Czech MP, Corvera S: Signaling mechanisms that regulate glucose transport. J Biol Chem 1999; 274(4): 1865-1878.

  77. Patki V, Lawe DC, Corvera S, Virbasius JV, Chwla A: A functional PtdIns(3)P-binding motif. Nature 1998; 394: 433-434.

  78. Tresguerres JAF: Fisiología Humana. Madrid Interamericana de España, McGraw-Hill, 1998.

  79. White M, Kahn CR: The insulin signalling system. J Biol Chem 1994; 269: 1-4.

  80. Klip A: Is intracellular Ca2+ involved in insulin stimulation of sugar transport? Fact and prejudice. Can J Biochem Cell Biol 1984; 62: 1228-1236.

  81. Valant P, Erlij D: K+ stimulated sugar uptake in skeletal muscle: role of cytoplasmic Ca2+. Am J Physiol 1983; 245: C125-132.




2020     |     www.medigraphic.com